Riely GJ, Smit EF, Ahn MJ, Felip E, et al. Phase II, Open-Label Study of Encorafenib Plus Binimetinib in Patients With BRAF(V600)-Mutant Metastatic Non-Small-Cell Lung Cancer. J Clin Oncol 2023 Jun 4:JCO2300774. doi: 10.1200/JCO.23.00774.
PMID: 37270692